Title of article
Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer: Abstracted from: Rocha Lima CM, Green MR, Rotche R et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherap
Author/Authors
Yip، نويسنده , , Desmond and Goldstein، نويسنده , , David، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
6
From page
236
To page
241
Journal title
Cancer Treatment Reviews
Serial Year
2005
Journal title
Cancer Treatment Reviews
Record number
1834652
Link To Document